Generic drugs are in high demand in growth markets in Europe and China and will quickly out pace the sale of name brand drugs.

One of the fastest growing markets will be for Type II diabetes medications as Western lifestyles and diseases encroach on the developing world.

Global sales growth of prescription drugs could be cut in half over the next five years as lucrative brands lose patent protection and cheaper generics and emerging markets become the only significant growth drivers, according to IMS Health.